Organ Preservation Market Size Global Report, 2022 - 2030
Organ Preservation Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030

Organ Preservation Market Share, Size, Trends, Industry Analysis Report, By Solution; By Technique; By End-User (Organ Transplant Centers, Hospitals, Specialty Clinics); By Organ Type (Kidney, Liver, Lung, Heart, Pancreas); By Region; Segment Forecast, 2022 - 2030

  • Published Date:May-2022
  • Pages: 112
  • Format: PDF
  • Report ID: PM2424
  • Base Year: 2021
  • Historical Data: 2018 - 2020

Report Outlook

The global organ preservation market was valued at USD 230.89 million in 2021 and is expected to grow at a CAGR of 6.8% during the forecast period. Technological advances are a significant driver of the organ preservation market's growth. Companies are currently striving to introduce technologically advanced protection and conservation solutions to overcome organ survival before transplantation and tissue edoema.

Organ Preservation Market SizeKnow more about this report: Request for sample pages

Persufflation, for example, is a promising and simple preservation technique that improves oxygenation, which improves grafting during conservation and protection, and transplantation. Further, governments worldwide are focusing on strengthening their healthcare infrastructures to provide better healthcare services. In India, for example, the Brihanmumbai Municipal Corporation (BMC) allocated around USD 924 Mn to improve health care services and establish 100 health centers with more than 100 diagnostic tests for health and curative care BMC areas.

Further, these infrastructure developments will increase the number of hospitals treating brain-dead patients who may be suitable donors. The increased number of testing laboratories will also shorten the time required for donor-recipient cross-matching, subject profiling, genetic testing, and other connected diagnostic tests before transplantation. These advancements are expected to open up new markets for the organ preservation market.

However, organ transplantation is a costly process that involves highly paid doctors, expensive transportation, and expensive drugs. Inpatient care, organ sourcing, preservation, post-operative recipient treatment, and anti-rejection medication add to the overall cost. As a result, one of the main factors limiting the growth of the organ preservation market is the high price of organ transplants.


Industry Dynamics

Growth Drivers
Chronic kidney disease (CKD), sepsis, and others increase organ preservation market demand in an emergency. Multiple organ failure is one of the most common causes of death in intensive care units, primarily caused by sepsis. According to the World Health Organization (WHO), sepsis is a diagnosis response to infection that is frequently the final standard route to death from several infectious diseases worldwide. The worldwide incidence of sepsis is difficult to estimate. As per the estimates of the WHO, there were 11 million sepsis-related deaths across the globe in 2017.

Further, according to the National Institute of Health, CKD affects more than one in every seven adults in the U.S., totaling 37 million people. Despite the availability of kidney disease in the U.S., up to 9 out of 10 people with CKD are unaware of their condition. Early-stage kidney infection generally has no symptoms, and many people are unaware they have CKD until it is advanced. Kidney disease frequently worsens over time and can lead to kidney failure and other health issues like stroke or heart attack.

As per the Centers for Disease Control and Prevention (CDC), CKD will be slightly more common in women (14%) than men (12%) in 2021. CKD affects approximately 14% of Hispanic adults. People aged 65 or older are the most likely to have CKD (38%), followed by those aged 45 to 64 (12%) and those aged 18 to 44 (6%). Thus, the rising prevalence of CKD and sepsis has increased kidney failures, driving the organ preservation market growth during the forecast period.

Organ Preservation Market
Know more about this report: Request for sample pages

Report Segmentation

The market is primarily segmented based on solution, technique, end-user, organ type, and region.

By Solution

By Technique

By End-User

By Organ Type

By Region

  • University of Wisconsin Solution (UW Solution)
  • Custodial HTK
  • Perfadex
  • Others
  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Organ Transplant Centers
  • Hospitals
  • Specialty Clinics
  • Kidney
  • Liver
  • Lung
  • Heart
  • Pancreas
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report: Request for sample pages

Insight by Organ Type

Based on the organ type segment, the kidney segment is expected to be the most significant revenue contributor due to an increase in kidney transplant procedures and cases of kidney failure. Various awareness campaigns promoting the benefits of kidney transplantation are also expected to drive segment growth. For example, the NHS launched the 'Advancing American Kidney Health' Initiative to enhance the lives of patients suffering from a kidney ailment in the U.S. Further, along with its broad applicability and increasing use, the static cold storage segment held the largest share.

Geographic Overview

In terms of geography, North America had the largest revenue share. Rising FDA approvals and the rising number of kidney diseases in the U.S. drive regional growth. For instance, in September 2021, TransMedics, a healthcare tech company trying to transform kidney transplantation treatments for patients with lung, and liver failure, confirmed that the U.S. Food and Drug Administration (FDA) had allowed pre-market approval (PMA) for its OCS Heart System to be used with organs from a donor after brain death (DBD).

Also, as per the CDC, more than one in seven, or 15% of U.S. adults, or 37 million people, are expected to have CKD in 2021 in the U.S. The region's need for preservation solutions to safeguard the viability of organs in ex-vivo climates is also a significant factor contributing to North America's big proportion of the organ preservation market. Further, as per the National Kidney Foundation (NKF), kidney ailments affect approximately 37 Mn people in the U.S. Approximately 90% of people with kidney disease are unaware of their condition. One in every three adults in the U.S. is at risk of kidney disease.

Moreover, Asia Pacific is expected to witness a high CAGR in the global market. This is due to rising healthcare expenditure, increased patient awareness, and increased market demand for organ transplantation procedures. The growing geriatric population, and increasing incidence of kidney and liver failure, are expected to drive market growth in the coming years. The major player's strategies in the region, such as increasing manufacturing facilities and rising investment by the public and private players, are driving the growth of the market in the region. For example, in July 2021, Institut Georges Lopez (IGL) is launching a production facility for organ preservation solutions in Cheyyar, Tamil Nadu. It will construct and operate a plant to assemble medical instruments and organ flushing and preservation solutions.

Competitive Insight

Major players operating in the global market include Bridge to Life Limited, Avionord, Carnamedica, Dr. Franz Kohler, Shanghai Genext, Transplant Biomedicals, Global Transplant Solutions, Essential Pharmaceuticals, Institut Georges Lopez, OrganOx Limited, Organ Preservation, Preservation Solutions, and Vascular Perfusion Solutions.

Organ Preservation Market Report Scope

Report Attributes


Market size value in 2021

USD 230.89 Million

Revenue forecast in 2030

USD 410.24 Million


6.8% from 2022 - 2030

Base year


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Segments covered

By Solution, By Technique, By End-User, By Organ Type, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key Companies

Avionord, Bridge to Life Limited, Carnamedica, Dr. Franz Kohler, Essential Pharmaceuticals, Global Transplant Solutions, Institut Georges Lopez, Organ Preservation, OrganOx Limited, Preservation Solutions, Shanghai Genext, Transplant Biomedicals, and Vascular Perfusion Solutions.